Virios Therapeutics, Inc. (VIRI)
After hours:
| Previous close | 0.3000 |
| Open | 0.3000 |
| Bid | 0.2910 x 1300 |
| Ask | 0.3090 x 900 |
| Day's range | 0.2951 - 0.3267 |
| 52-week range | 0.2580 - 9.1110 |
| Volume | |
| Avg. volume | 753,222 |
| Market cap | 5.492M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.0240 |
| Earnings date | 12 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.00 |
- Business Wire
Virios Therapeutics, Inc. to Present at the Virtual Planet MicroCap Showcase
ATLANTA, November 29, 2022--Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia, today announced that Greg Duncan, Chairman and CEO of Virios Therapeutics will be attending and presenting at the Planet MicroCap Showcase, which is taking place virtually December 6 – 8, 2022.
- Business Wire
Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
ATLANTA, November 14, 2022--Virios Therapeutics, Inc. (Nasdaq: VIRI) (the "Company"), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases including fibromyalgia ("FM"), today announced financial results for the third quarter ended September 30, 2022, as well as plans to advance development of its lead antiviral development candidate, IMC-1, as a potential new treatment for FM patients.
- Business Wire
Virios Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Monday, November 14, 2022
ATLANTA, November 03, 2022--Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia, announced today that its third quarter 2022 financial results will be reported on Monday, November 14, 2022 before the open of the financial markets. Management will also host a webcast and conference call on November 14, 2022 at 8:30 a.m. ET to discuss the result
